Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARVEL: CS-8958 vs Oseltamivir in Influenza
NCT00803595Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of laninamivir octanoate in influenza, sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2008; status: completed.
02
Drugs
laninamivir octanoate
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00803595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803595.